Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company QOL Medical LLC
DescriptionSacrosidase enzyme replacement therapy
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard Indication Metabolic (unspecified)
Indication DetailsTreat congenital sucrase-isomaltase deficiency (CSID)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today